MX376869B - Metodos utiles en la sintesis de analogos de halicondrina b. - Google Patents

Metodos utiles en la sintesis de analogos de halicondrina b.

Info

Publication number
MX376869B
MX376869B MX2019011926A MX2019011926A MX376869B MX 376869 B MX376869 B MX 376869B MX 2019011926 A MX2019011926 A MX 2019011926A MX 2019011926 A MX2019011926 A MX 2019011926A MX 376869 B MX376869 B MX 376869B
Authority
MX
Mexico
Prior art keywords
halichondrin
synthesis
analogues
useful methods
eribulin
Prior art date
Application number
MX2019011926A
Other languages
English (en)
Spanish (es)
Other versions
MX2019011926A (es
Inventor
Bryan M Lewis
Hiroyuki Chiba
Huiming Zhang
Yongbo Hu
Yuki Komatsu
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of MX2019011926A publication Critical patent/MX2019011926A/es
Publication of MX376869B publication Critical patent/MX376869B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2019011926A 2013-12-06 2014-12-05 Metodos utiles en la sintesis de analogos de halicondrina b. MX376869B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361912714P 2013-12-06 2013-12-06
PCT/US2014/068834 WO2015085193A1 (en) 2013-12-06 2014-12-05 Methods useful in the synthesis of halichondrin b analogs

Publications (2)

Publication Number Publication Date
MX2019011926A MX2019011926A (es) 2019-11-18
MX376869B true MX376869B (es) 2025-03-07

Family

ID=53270478

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2019011926A MX376869B (es) 2013-12-06 2014-12-05 Metodos utiles en la sintesis de analogos de halicondrina b.
MX2020004855A MX384292B (es) 2013-12-06 2014-12-05 Metodos utiles en la sintesis de analogos de halicondrina b.
MX2016006891A MX370611B (es) 2013-12-06 2014-12-05 Metodos utiles en la sintesis de analogos de halicondrina b.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2020004855A MX384292B (es) 2013-12-06 2014-12-05 Metodos utiles en la sintesis de analogos de halicondrina b.
MX2016006891A MX370611B (es) 2013-12-06 2014-12-05 Metodos utiles en la sintesis de analogos de halicondrina b.

Country Status (13)

Country Link
US (4) US9303039B2 (enExample)
EP (2) EP3505520A1 (enExample)
JP (3) JP6443812B2 (enExample)
CN (1) CN105916861B (enExample)
BR (1) BR112016012237B1 (enExample)
CA (1) CA2931788C (enExample)
ES (1) ES2723355T3 (enExample)
HU (1) HUE043088T2 (enExample)
IL (4) IL245661A0 (enExample)
MX (3) MX376869B (enExample)
RU (1) RU2676486C1 (enExample)
SG (2) SG10201805024YA (enExample)
WO (1) WO2015085193A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2522663B1 (en) 2004-06-03 2015-04-01 Eisai R&D Management Co., Ltd. Intermediates for the preparation of halichondrin B
RU2489437C2 (ru) 2007-10-03 2013-08-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Промежуточные соединения и способы синтеза аналогов галихондрина в
US8598373B2 (en) 2008-04-04 2013-12-03 Eisai R&D Management Co., Ltd. Halichondrin B analogs
JP5800834B2 (ja) 2010-01-26 2015-10-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンb類似体の合成において有用なフロ[3,2−b]ピラン誘導体
CN114716453A (zh) 2013-11-04 2022-07-08 卫材R&D管理有限公司 软海绵素b的类似物合成中有用的大环化反应和中间体
JP6443812B2 (ja) * 2013-12-06 2018-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンb類縁体の合成に有用な方法
JP2017520586A (ja) 2014-06-30 2017-07-27 プレジデント アンド フェローズ オブ ハーバード カレッジ ハリコンドリン類似体の合成およびその使用
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
WO2016179607A1 (en) 2015-05-07 2016-11-10 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides
MX377663B (es) 2016-02-12 2025-03-11 Eisai R&D Man Co Ltd Intermediarios en la sintesis de eribulina y metodos de sintesis relacionados.
EP3423105B1 (en) 2016-03-02 2021-05-05 Eisai R&D Management Co., Ltd. Eribulin-based antibody-drug conjugates and methods of use
MX390072B (es) 2016-06-30 2025-03-20 Eisai R&D Man Co Ltd Reaccion de prins e intermediarios utiles en la sintesis de macrolidos de halicondrina y analogos de los mismos.
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
HUE060466T2 (hu) 2017-04-05 2023-03-28 Harvard College Makrociklusos vegyület és alkalmazása
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
WO2018217894A1 (en) * 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Fluorine-labelled halichondrin derivatives and related methods of synthesis
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
BR112020000141A2 (pt) 2017-07-06 2020-07-14 President And Fellows Of Harvard College síntese de halicondrinas
CN109694379B (zh) * 2017-10-24 2020-09-11 江苏恒瑞医药股份有限公司 用于制备艾日布林的中间体及其制备方法
ES2974243T3 (es) 2017-11-15 2024-06-26 Harvard College Compuestos macrocíclicos y usos de los mismos
WO2019097073A1 (en) 2017-11-20 2019-05-23 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of neoplastic diseases
CN111868044B (zh) 2018-01-03 2024-07-19 卫材R&D管理有限公司 可用于合成软海绵素大环内酯及其类似物的普林斯反应和化合物
CN112437775A (zh) * 2018-07-20 2021-03-02 雷迪博士实验室有限公司 用于制备艾日布林及其中间体的纯化方法
CN113166096A (zh) * 2018-10-09 2021-07-23 雷迪博士实验室有限公司 制备艾立布林的方法及其中间体
US20220089607A1 (en) * 2018-11-28 2022-03-24 Natco Pharma Limited Process for the preparation of high pure eribulin and its mesylate salt
US11447499B2 (en) 2019-06-14 2022-09-20 Rk Pharma Inc. Process for the preparation of eribulin mesylate intermediate
WO2022101931A1 (en) * 2020-11-10 2022-05-19 Natco Pharma Limited Process for the preparation of eribulin and its intermediates
CN113354659B (zh) * 2021-06-08 2022-04-08 江苏慧聚药业股份有限公司 甲磺酸艾日布林的合成
CN114380840B (zh) * 2022-01-27 2024-01-26 江苏慧聚药业股份有限公司 艾日布林的合成
WO2025106586A1 (en) * 2023-11-13 2025-05-22 Luxvitae Therapeutics Inc. Macrocyclic ketone compounds and applications thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU652180A1 (ru) 1975-12-16 1979-03-15 Краснодарский политехнический институт 1(Фурил-2,)-2-(2-,, формилфурил-5,, ) этилен или его метильное производное как промежуточный продукт дл синтеза фуран-2,5-дикарбоновой кислоты и способ его получени
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
TW255880B (enExample) 1992-09-09 1995-09-01 Hoechst Ag
US6194586B1 (en) * 1996-09-06 2001-02-27 Eli Lilly And Company Selective sulphonation of the primary alcohol of a diol containing both primary and secondary alcohols
CN1216051C (zh) 1998-06-17 2005-08-24 卫材株式会社 大环类似物及其使用和制备的方法
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
CN109180615A (zh) * 2004-06-03 2019-01-11 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体
EP2522663B1 (en) * 2004-06-03 2015-04-01 Eisai R&D Management Co., Ltd. Intermediates for the preparation of halichondrin B
US20060045846A1 (en) 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
EP1831697A4 (en) 2004-12-09 2011-01-26 Eisai R&D Man Co Ltd SCREENING OF TUBULIN ISOTYPE IN CANCER THERAPY USING ANALOGUES OF HALICHONDRIN B
WO2008010776A1 (en) 2006-07-21 2008-01-24 Agency For Science, Technology And Research Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection
JPWO2009014105A1 (ja) 2007-07-20 2010-10-07 株式会社山田養蜂場本社 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
RU2489437C2 (ru) 2007-10-03 2013-08-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Промежуточные соединения и способы синтеза аналогов галихондрина в
CA2705383A1 (en) 2007-11-16 2009-05-22 Eisai R&D Management Co., Ltd. Novel intermediate for halichondrin b analog synthesis and novel desulfonylation reaction used for the intermediate
US8598373B2 (en) * 2008-04-04 2013-12-03 Eisai R&D Management Co., Ltd. Halichondrin B analogs
JP5371091B2 (ja) 2009-01-23 2013-12-18 三菱レイヨン株式会社 モノスルホン酸エステルの製造方法
JP5800834B2 (ja) 2010-01-26 2015-10-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンb類似体の合成において有用なフロ[3,2−b]ピラン誘導体
EP2354128A1 (en) 2010-02-10 2011-08-10 Sandoz Ag Method for the preparation of rivaroxaban
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
EP2785687B1 (en) 2011-11-30 2019-02-20 Sandoz AG Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
EP2831082B1 (en) 2012-03-30 2019-02-20 Sandoz AG Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein
CA2916537C (en) 2013-07-03 2021-07-27 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
CN114716453A (zh) 2013-11-04 2022-07-08 卫材R&D管理有限公司 软海绵素b的类似物合成中有用的大环化反应和中间体
JP6443812B2 (ja) * 2013-12-06 2018-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンb類縁体の合成に有用な方法
WO2016179607A1 (en) 2015-05-07 2016-11-10 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides
MX377663B (es) 2016-02-12 2025-03-11 Eisai R&D Man Co Ltd Intermediarios en la sintesis de eribulina y metodos de sintesis relacionados.
MX390072B (es) 2016-06-30 2025-03-20 Eisai R&D Man Co Ltd Reaccion de prins e intermediarios utiles en la sintesis de macrolidos de halicondrina y analogos de los mismos.

Also Published As

Publication number Publication date
MX2020004855A (es) 2021-07-08
BR112016012237A2 (enExample) 2017-08-08
WO2015085193A1 (en) 2015-06-11
US10030032B2 (en) 2018-07-24
US9695188B2 (en) 2017-07-04
US20160176895A1 (en) 2016-06-23
SG10201805024YA (en) 2018-07-30
CN105916861A (zh) 2016-08-31
US20150158881A1 (en) 2015-06-11
IL281275A (en) 2021-04-29
IL245661A0 (en) 2016-06-30
EP3077399A1 (en) 2016-10-12
US20190010166A1 (en) 2019-01-10
EP3077399B1 (en) 2019-02-20
MX370611B (es) 2019-12-18
IL273736B (en) 2021-03-25
RU2676486C1 (ru) 2018-12-29
MX2016006891A (es) 2017-06-12
JP2016540752A (ja) 2016-12-28
IL265640A (en) 2019-05-30
JP2019031530A (ja) 2019-02-28
US10450324B2 (en) 2019-10-22
MX2019011926A (es) 2019-11-18
JP2020059739A (ja) 2020-04-16
JP6634135B2 (ja) 2020-01-22
IL273736A (en) 2020-05-31
US20170298078A1 (en) 2017-10-19
IL265640B (en) 2020-04-30
BR112016012237B1 (pt) 2023-02-07
MX384292B (es) 2025-03-14
US9303039B2 (en) 2016-04-05
CA2931788A1 (en) 2015-06-11
EP3077399A4 (en) 2017-05-10
ES2723355T3 (es) 2019-08-26
EP3505520A1 (en) 2019-07-03
SG11201604545XA (en) 2016-07-28
CA2931788C (en) 2022-05-24
JP6905041B2 (ja) 2021-07-21
IL281275B (en) 2021-12-01
HUE043088T2 (hu) 2019-08-28
JP6443812B2 (ja) 2018-12-26
CN105916861B (zh) 2018-12-14

Similar Documents

Publication Publication Date Title
MX376869B (es) Metodos utiles en la sintesis de analogos de halicondrina b.
CY1123953T1 (el) Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης
EA201791304A1 (ru) Производные изохинолина для лечения вич
CR20160419A (es) Nuevos compuestos biciclicos
EA201791256A1 (ru) Производные хиназолина, применяемые для лечения вич
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201591420A1 (ru) Гетероарильные соединения и их применение
PH12016500739B1 (en) Inhibitors of the fibrolast growth factor receptor
EA201991715A1 (ru) Композиции, содержащие антитело к pdl1
EA201790407A1 (ru) Зонды для визуализации белка хантингтина
CR20150524A (es) Compuestos de heteroarilo y sus usos
MD20150100A2 (ro) Virusurile bolii de Newcastle şi utilizarea acestora
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
EA201692219A1 (ru) Способы получения противовирусных соединений
MX2017014237A (es) Reacciones de macro-ciclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
UY35684A (es) Formulación de inhibidores de la tirosina quinasa de bazo (syk)
EA201791058A1 (ru) Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4)
EA201591805A1 (ru) Оксабицикло [2.2.2] кислоты - модуляторы gpr120
CY1122313T1 (el) Ορβεπιταντη για την αγωγη του χρονιου κνησμου
EA201591712A1 (ru) Антибиотические композиции на основе цефтолозана
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
EA201790400A1 (ru) Зонды для визуализации белка хантингтина
EA201791600A1 (ru) Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
CY1119907T1 (el) Ενα παραγωγο χρωμονης ως ενας ανταγωνιστης του d3 υποδοχεα ντοπαμινης για τη χρηση του στην αντιμετωπιση διαταραχης του φασματος του αυτισμου
EA201591717A1 (ru) Твердые формы гидрохлорида вемурафениба

Legal Events

Date Code Title Description
FG Grant or registration